Ignite Creation Date:
2025-12-24 @ 3:34 PM
Ignite Modification Date:
2026-03-06 @ 10:10 PM
Study NCT ID:
NCT02937792
Status:
UNKNOWN
Last Update Posted:
2016-10-19
First Post:
2016-10-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section
Sponsor:
Cairo University
Organization:
Study Overview
Official Title:
Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section
Status:
UNKNOWN
Status Verified Date:
2016-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To test the safety of high dose spinal in elective CS after prolonged sitting position.
Detailed Description:
This is a prospective double-blind randomized study, designed to include cases in two groups (using epical program for sample size calculation), one study groups and one control group (parallel). Each group should have at least 30 female patients scheduled for elective caesarean section with a total of 60 cases.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: